Impact of Immunoscore on the Management of Stage II Colon Cancer Patients: A Physician Survey

SIMPLE SUMMARY: Selection of appropriate stage II colon cancer patients for adjuvant chemotherapy (AC) is controversial. A novel immune response classifier has previously been validated to refine patient selection, but its impact on oncologist treatment planning had yet to be described. In this surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasi, Anup, Dotan, Efrat, Poage, Graham M., Catteau, Aurelie, Vernerey, Dewi, George, Manju, Barzi, Afsaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582441/
https://www.ncbi.nlm.nih.gov/pubmed/34771628
http://dx.doi.org/10.3390/cancers13215467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582441/
https://www.ncbi.nlm.nih.gov/pubmed/34771628
http://dx.doi.org/10.3390/cancers13215467

Ejemplares similares